pancreatic cancer
| 4 min read
Early clinical trials show that a KRAS G12D inhibitor can shrink tumors in patients with advanced pancreatic and other solid cancers.
| 3 min read
Final results from the AMPLIFY-201 phase 1 trial highlight durable T cell responses and prolonged survival in patients with colorectal and pancreatic cancer.
| 3 min read
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker
| 4 min read
From layoffs at the FDA, CDC, and NIH to a blood test for Alzheimer’s disease and a starfish-inspired diagnostic, the DDN team breaks down this week’s news.
| 2 min read
Researchers showed that pancreatic cancer stem cells produce a protein usually made by neutrophils to evade the immune system and keep growing.
| 4 min read
A new mouse study suggests that folinic acid treatment could help the immune system penetrate pancreatic cancer’s protective shell.
| 3 min read
An experimental drug significantly reduced tumor burden and extended survival in mice with pancreatic cancer.
| 4 min read
Researchers identified immune cell imposters that are responsible for immune evasion in pancreatic cancer.
| 8 min read
The live virus in the smallpox vaccine boosts the activity of cancer-killing immune cells for hard-to-treat tumors.
| 3 min read
Study finds combination therapy with NAMPT inhibitors and STING agonists can suppress pancreatic tumor growth in mice
